We are live on ! Find out more
TECX

Tectonic Therapeutic

48 hedge funds and large institutions have $22.8M invested in Tectonic Therapeutic in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more call options, than puts

Call options by funds: $13K | Put options by funds: $1K

54% more capital invested

Capital invested by funds: $14.8M → $22.8M (+$8.03M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

7% more funds holding

Funds holding: 4548 (+3)

0.36% more ownership

Funds ownership: 3.96%4.32% (+0.36%)

0% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 12

Holders
48
Holders Change
+3
Holders Change %
+6.67%
% of All Funds
0.76%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
12
Reduced
12
Closed
8
Calls
$13K
Puts
$1K
Net Calls
+$12K
Net Calls Change
+$7K
Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$4.54M +$23.8K +1,709 +0.5%
GC
2
GMT Capital
Georgia
$4.36M +$1.22M +87,333 +32%
FCM
3
Farallon Capital Management
California
$3.12M +$2.76M +198,000 +321%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$1.77M +$348K +25,021 +20%
BlackRock
5
BlackRock
New York
$1.39M -$147K -10,581 -8%
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.18M +$26.6K +1,907 +2%
ACM
7
Aisling Capital Management
New York
$1.01M
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$650K +$754K +54,167 New
MB
9
MPM BioImpact
Massachusetts
$648K
Renaissance Technologies
10
Renaissance Technologies
New York
$573K -$335K -24,075 -34%
Citadel Advisors
11
Citadel Advisors
Florida
$506K -$88.9K -6,385 -13%
Two Sigma Investments
12
Two Sigma Investments
New York
$333K +$17.6K +1,262 +5%
Two Sigma Advisers
13
Two Sigma Advisers
New York
$332K -$11.3K -808 -3%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$331K -$64.3K -4,617 -14%
NLVP
15
New Leaf Venture Partners
New York
$316K
SW
16
SVB Wealth
Massachusetts
$284K
JP Morgan Chase
17
JP Morgan Chase
New York
$208K +$214K +15,365 +781%
Morgan Stanley
18
Morgan Stanley
New York
$203K -$395K -28,382 -63%
Millennium Management
19
Millennium Management
New York
$176K -$595K -42,762 -75%
State Street
20
State Street
Massachusetts
$141K
Wells Fargo
21
Wells Fargo
California
$137K +$55.2K +3,967 +53%
BCM
22
Bridgeway Capital Management
Texas
$106K -$58K -4,167 -32%
PFMU
23
Privium Fund Management (UK)
United Kingdom
$85.1K -$204K -14,628 -67%
Northern Trust
24
Northern Trust
Illinois
$75.5K +$1.77K +127 +2%
B
25
Bailard
California
$45.5K +$22.9K +1,642 +76%

TECX Hedge Fund Activity: Q1 2023 in Review

48 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q1 2023, worth a combined $22.8M — up 54% from $14.8M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new TECX positions and 8 closed out — a net gain of 3 holders — while 12 added to existing stakes and 12 trimmed.

The largest buyer was Farallon Capital Management, adding an estimated $2.76M. The largest seller was Natixis, exiting entirely with an estimated $627K sold.

  • 48 institutional investors held Tectonic Therapeutic (TECX) as of Q1 2023, up from 45 in Q4 2022.
  • Funds reported $22.8M of Tectonic Therapeutic stock for Q1 2023, up 54% quarter-over-quarter.
  • 11 funds opened new Tectonic Therapeutic positions in Q1 2023 and 8 closed out, a net change of +3 holders.
  • The largest Tectonic Therapeutic buyer in Q1 2023 was Farallon Capital Management, an estimated $2.76M added.
  • The largest Tectonic Therapeutic seller in Q1 2023 was Natixis, an estimated $627K sold.

Based on aggregated 13F filings for Q1 2023.